The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. marketing ...

Twenty-six years of chasing New York City sex crimes as the face of “Law & Order: Special Victims Unit” has prepared ...

It’s a sign of the times that this year’s American Diabetes Association (ADA) Scientific Sessions meeting in New Orleans ...

The new expansion covers all patients 6 and older, regardless of their inhibitor status. The new nod also opens up the ...

For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first ...

In the persistence and adherence analysis, which looked at 28 studies including 267,542 patients, Amgen found that 69% of ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government ...

The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative which could ...

The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. | The drumbeat of news regarding ...

Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...